<!DOCTYPE html>
<html lang="en">
 <head>
  <meta charset="utf-8"/>
  <meta content="origin" name="referrer"/>
  <meta content="/images/branding/googleg/1x/googleg_standard_color_128dp.png" itemprop="image"/>
  <title>
   What is Evant, Inc.'s relationship to Stiefel Laboratories? - Google Search
  </title>
  <style>
   a{color:#1a0dab;text-decoration:none;-webkit-tap-highlight-color:rgba(0,0,0,.10)}a:visited{color:#4b11a8}a:hover{text-decoration:underline}img{border:0}html{font-family:arial,sans-serif;font-size:14px;line-height:20px;-webkit-text-size-adjust:100%;color:#3c4043;word-wrap:break-word;background-color:#fff}.bz1lBb{background-color:#fff;height:93px;}.KP7LCb{background-color:#fff;padding-left:4px}.BsXmcf{position:absolute;height:1px;left:0;right:0;background-color:#dadce0}.cOl4Id{background-color:#fff}.bRsWnc{overflow:hidden}.N6RWV{height:51px}.Uv67qb{font-size:14px;line-height:20px;font-weight:bold;display:flex}.Uv67qb a,.Uv67qb span{color:#5e5e5e;height:20px;margin:4px 12px 1px;display:block;flex:none;text-align:center;}.OXXup{border-bottom:2px solid #1f1f1f}.Uv67qb .OXXup{font-weight:bold;color:#1f1f1f}a.eZt8xd:visited{color:#5e5e5e}.FElbsf{border-left:1px solid #dadce0}header article{overflow:visible}.Pg70bf{height:39px;display:-webkit-box;display:flex;display:flex;width:100%}.H0PQec{position:relative;flex:1}.Pg70bf{height:26px}.hlm7Y{height:46px;margin-top:26px;border-radius:25px;width:auto;background:#fff;box-shadow:0px 2px 6px rgba(60,64,67,0.16)}.sbc{display:flex}.Pg70bf input{}.x{width:26px;color:#70757a;line-height:40px;margin-top:3px;font:27px/38px arial, sans-serif}#qdClwb{flex:0 0 auto;padding:0;height:33px;margin-top:5px;border-top-right-radius:25px;border-bottom-right-radius:25px;width:48px;background:#fff;border:0;border-left:1px solid #dadce0;background-image:url('data:image/svg+xml,\00003csvg height="37px" width="37px" xmlns="http://www.w3.org/2000/svg">\00003cg fill="none" stroke="%234285F4">\00003cellipse cx="16.5" cy="16" rx="5.4" ry="5.4" stroke-width="2px">\00003c/ellipse>\00003cpath d="M22 21.3l4.3 4.3" stroke-linecap="round" stroke-width="2px">\00003c/path>\00003c/g>\00003c/svg>');}.sc{font-size:16px;position:absolute;top:48px;left:0;right:0;box-shadow:0 2px 5px rgba(0,0,0,.2);z-index:2;background-color:#fff}.sc>div{padding:10px 20px}.scs{background-color:#fafafa;}.noHIxc{display:block;font-size:16px;padding:0 0 0 8px;flex:1;height:35px;outline:none;border:none;width:100%;-webkit-tap-highlight-color:rgba(0,0,0,0);overflow:hidden;padding:4px 0 0 20px}.sbc input[type=text]{background:none}html{background-color:#fff;}body{padding:0;}body{margin:0 auto 0 156px;max-width:652px;min-width:652px;padding:0 8px}.cOl4Id{text-align:center;padding:32px 28px 0 24px;position:absolute;left:0;top:0}footer{text-align:center;margin-top:18px}footer a,footer a:visited,.smiUbb{color:#70757a}.xeDNfc{margin:0 13px;display:inline-block}#EOlPnc{margin-top:36px}#EOlPnc>div{margin:20px}.Srfpq{color:#70757a}
  </style>
 </head>
 <body jsmodel="hspDDf ">
  <header id="hdr">
   <div class="cOl4Id">
    <a href="/?sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQOwgC">
     <svg aria-label="Google" fill="none" height="36" stroke="#4285f4" stroke-width="18" viewbox="0 0 520 174" width="92">
      <path d="M69 70.4l61 0m-9 3.5a56 57 0 1 1-17-47" stroke-width="19px">
      </path>
      <ellipse cx="179" cy="90" rx="33" ry="34" stroke="#ea4335">
      </ellipse>
      <ellipse cx="270" cy="90" rx="33" ry="34" stroke="#fbbc04">
      </ellipse>
      <ellipse cx="358" cy="90" rx="32" ry="34" stroke-width="17px">
      </ellipse>
      <path d="M391 49l0 73l-2 0a 22 22-30 0 1-59 24">
      </path>
      <path d="M423 5l0 130" style="stroke:#34a853">
      </path>
      <path d="M509 110a32 35-3 1 1 3-29M517 76l-63 24" stroke="#ea4335" stroke-width="16px">
      </path>
     </svg>
    </a>
   </div>
   <div class="bz1lBb">
    <form class="Pg70bf hlm7Y" id="sf">
     <input name="num" type="hidden" value="100"/>
     <input name="lr" type="hidden" value="lang_en"/>
     <input name="sca_esv" type="hidden" value="1402386822cb5d18"/>
     <input name="hl" type="hidden" value="en"/>
     <input name="gbv" type="hidden" value="1"/>
     <input name="gl" type="hidden" value="us"/>
     <input name="tbs" type="hidden" value="lr:lang_1en"/>
     <div class="H0PQec">
      <div class="sbc esbc">
       <input autocapitalize="none" autocomplete="off" class="noHIxc" name="q" spellcheck="false" type="text" value="What is Evant, Inc.'s relationship to Stiefel Laboratories?"/>
       <input name="oq" type="hidden"/>
       <input name="aqs" type="hidden"/>
       <div class="sc">
       </div>
      </div>
     </div>
     <button id="qdClwb" type="submit">
     </button>
    </form>
   </div>
  </header>
  <div id="main">
   <div>
    <div class="KP7LCb">
     <div class="bRsWnc">
      <div class="N6RWV">
       <div class="Pg70bf Uv67qb">
        <span class="OXXup">
         All
        </span>
        <a class="eZt8xd" href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=nws&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ_AUIBigB">
         News
        </a>
        <a class="eZt8xd" href="/url?q=https://maps.google.com/maps%3Fhl%3Den%26q%3DWhat%2Bis%2BEvant,%2BInc.%2527s%2Brelationship%2Bto%2BStiefel%2BLaboratories%253F%26iflsig%3DAL9hbdgAAAAAZpb1q1qIWmvt_hmdJKxygxVBozIbC1E8%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26um%3D1%26ie%3DUTF-8%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQiaAMCAcoAg&amp;usg=AOvVaw32KX3QNFD4y7Jgr_iWIqBx">
         Maps
        </a>
        <a class="eZt8xd" href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=bks&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ_AUICCgD">
         Books
        </a>
        <a href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=isch&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ_AUICSgE">
         Images
        </a>
        <a href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=vid&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ_AUICigF">
         Videos
        </a>
        <a href="/url?q=/search%3Fq%3DWhat%2Bis%2BEvant,%2BInc.%2527s%2Brelationship%2Bto%2BStiefel%2BLaboratories%253F%26num%3D100%26lr%3Dlang_en%26sca_esv%3D1402386822cb5d18%26hl%3Den%26gbv%3D1%26gl%3Dus%26tbs%3Dlr:lang_1en%26tbm%3Dshop%26source%3Dlnms%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQiaAMCAsoBg&amp;usg=AOvVaw3SdNfYzINGNABXhBamxUX6">
         Shopping
        </a>
        <div class="FElbsf">
         <a href="/advanced_search" id="st-toggle" role="button" style="white-space:nowrap">
          Search tools
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
    <div class="Pg70bf wEsjbd Gx5Zad xpd EtOod pkphOe" id="st-card">
     <style>
      .wEsjbd{height:44px;white-space:nowrap}.coPU8c{height:60px;-webkit-overflow-scrolling:touch;overflow-x:auto;overflow-y:hidden}.Xj2aue{height:44px;overflow:hidden}.RnNGze{margin:11px 16px}.wEsjbd div,.wEsjbd a,.wEsjbd li{outline-width:0;outline:none}
     </style>
     <div class="Xj2aue">
      <div class="coPU8c">
       <div class="RnNGze">
        <style>
         .PA9J5{display:inline-block}.RXaOfd,.tbcPJb{display:inline-block;height:22px;position:relative;padding-top:0;padding-bottom:0;padding-right:16px;padding-left:0;line-height:22px;cursor:pointer;text-transform:uppercase;font-size:12px;color:#70757a}.sa1toc{background:#fff;display:none;position:absolute;border:1px solid #dadce0;box-shadow:0 2px 4px rgba(0,0,0,.3);margin:0;white-space:nowrap;z-index:103;line-height:17px;padding-top:5px;padding-bottom:5px;padding-left:0}.PA9J5:hover .sa1toc{display:block}.mGSy8d a:active,.RXaOfd:active{color:#4285f4}
        </style>
        <div class="PA9J5">
         <div class="RXaOfd vQYuGf" role="button" tabindex="0">
          <style>
           .TWMOUc{display:inline-block;padding-right:14px;white-space:nowrap}.vQYuGf{font-weight:bold}.OmTIzf{border-color:#909090 transparent;border-style:solid;border-width:4px 4px 0 4px;width:0;height:0;margin-left:-10px;top:50%;margin-top:-2px;position:absolute}.RXaOfd:active .OmTIzf{border-color:#4285f4 transparent}
          </style>
          <div class="TWMOUc">
           Search English pages
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <style>
           .ozatM{font-size:12px;text-transform:uppercase}.ozatM .yNFsl,.ozatM li{list-style-type:none;list-style-position:outside;list-style-image:none}.yNFsl.SkUj4c,.yNFsl a{color:#70757a;text-decoration:none;padding:6px 44px 6px 14px;line-height:17px;display:block}.SkUj4c{background-image:url(//ssl.gstatic.com/ui/v1/menu/checkmark2.png);background-position:right center;background-repeat:no-repeat}.SkUj4c:active{background-color:#f8f9fa}
          </style>
          <li class="yNFsl">
           <style>
            .tbcPJb a{color:#70757a;text-decoration:none}
           </style>
           <a href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbas=0&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQpwUIDA">
            Any language
           </a>
          </li>
          <li class="yNFsl SkUj4c">
           Search English pages
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           Any time
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           Any time
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:h&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQpwUIDw">
            Past hour
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:d&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQpwUIEA">
            Past 24 hours
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:w&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQpwUIEQ">
            Past week
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:m&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQpwUIEg">
            Past month
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:y&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQpwUIEw">
            Past year
           </a>
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           All results
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           All results
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=li:1&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQpwUIFQ">
            Verbatim
           </a>
          </li>
         </ul>
        </div>
        <div class="tbcPJb" role="button" tabindex="0">
         <a href="https://www.google.com/search?hl=en&amp;source=hp&amp;q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;btnG=Google+Search&amp;iflsig=AL9hbdgAAAAAZpb1q1qIWmvt_hmdJKxygxVBozIbC1E8&amp;gbv=1&amp;gl=us&amp;num=100">
          Clear
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div class="BsXmcf">
   </div>
   <style>
    .Gx5Zad{margin-bottom:30px;margin:0px 0px 8px;}.pkphOe{font-size:14px;line-height:22px;}.EtOod>*:first-child{border-top-left-radius:8px;border-top-right-radius:8px}.EtOod>*:last-child{border-bottom-left-radius:8px;border-bottom-right-radius:8px}.EtOod.avPKgf>*:last-child{border-bottom-left-radius:4px}.EtOod>.qxDOhb>*:first-child{border-top-left-radius:8px;border-top-right-radius:8px}.EtOod>.qxDOhb>*:last-child{border-bottom-left-radius:8px;border-bottom-right-radius:8px}.fP1Qef{background:transparent !important;box-shadow:none !important;border:none !important}.rl7ilb{display:block;clear:both}.egMi0{margin-bottom:-23px}.kCrYT{padding:16px 14px 12px}a.fdYsqf{color:#4b11a8}.sCuL3{position:absolute;width:100%;top:0;left:0;padding-top:1px;margin-bottom:-1px}.j039Wc{padding-top:28px;margin-bottom:-1px}.DnJfK{position:relative}.l97dzf{font-weight:400}.zBAuLc{line-height:normal;margin:0;padding:0}.BNeawe{white-space:pre-line;word-wrap:break-word}.vvjwJb{color:#1a0dab;font-size:20px;line-height:26px}a:visited .vvjwJb,.vvjwJb a:visited{color:#4b11a8}.vvjwJb.HrGdeb{color:#fff}a:visited .vvjwJb.HrGdeb,.vvjwJb.HrGdeb a:visited{color:rgba(255,255,255,.70)}.UwRFLe{display:-webkit-box;-webkit-box-orient:vertical;overflow:hidden}.UPmit{font-size:14px;line-height:22px}.UPmit.HrGdeb{color:rgba(255,255,255,.70)}.UPmit.AP7Wnd{color:#202124}.lRVwie{text-overflow:ellipsis;white-space:nowrap;overflow:hidden}.Ap5OSd{padding-bottom:12px}.s3v9rd{font-size:14px;line-height:22px}.s3v9rd.HrGdeb{color:#fff}.s3v9rd.AP7Wnd{color:#202124}.mSx1Ee{padding-left:48px;margin:0}.v9i61e{padding-bottom:8px}.r0bn4c.tr0dw{color:rgba(255,255,255,.70)}.r0bn4c.rQMQod{color:#70757a}.U8ml0d{text-decoration:line-through}.XLloXe{color:#1a0dab;font-size:14px;line-height:20px}a:visited .XLloXe,.XLloXe a:visited{color:#4b11a8}.XLloXe.HrGdeb{color:#fff}a:visited .XLloXe.HrGdeb,.XLloXe.HrGdeb a:visited{color:rgba(255,255,255,.70)}.cAuxJf{font-size:20px;font-weight:bold;line-height:26px;color:#1f1f1f;margin:0}.tAd8D{font-size:14px;line-height:20px}.tAd8D.HrGdeb{color:rgba(255,255,255,.70)}.tAd8D.AP7Wnd{color:#70757a}.Xb5VRe{color:#1a0dab}a:visited .Xb5VRe{color:#4b11a8}.Xb5VRe.tr0dw{color:#fff}a:visited .Xb5VRe.tr0dw{color:rgba(255,255,255,.70)}.Xdlr0d{overflow-x:auto;-webkit-overflow-scrolling:touch;margin:0 -8px;padding:2px 0 16px 22px;margin-top:-2px;transform:translate3d(0,0,0)}.idg8be{display:table;border-collapse:separate;border-spacing:8px 0;margin:0 -8px;padding-right:14px}.BVG0Nb{display:table-cell;vertical-align:top;overflow:hidden;}.pijXPc{overflow:hidden;border-radius:16px;background-color:#f7f8f9;font-size:18px}.OxTOff{overflow:hidden;border-radius:8px;background-color:#f7f8f9}.WddBJd{display:block;margin:0 auto;border-radius:8px}.RJI4s{vertical-align:middle}.mHhylf{display:table-cell;vertical-align:middle}.WZ5GJf{align-items:center;padding:0 20px;min-width:112px}.qN9Ked,.DXk5Me{margin:0 auto;color:#001d35}.DXk5Me{cursor:pointer;margin-bottom:12px}.Dk7jOe{display:block;margin:0 auto}.Qi9Fd{border:0;border-radius:999px;display:block;height:56px;justify-content:center;width:56px;z-index:0;background:#f7f8f9;}.Qi9Fd:focus{outline:none}.Qi9Fd .hWHuJ{display:block;margin:0 auto}.ji5jpf{text-align:center}.rLshyf,.BmP5tf{padding-top:16px;padding-bottom:12px}.YOx3Ab{padding-left:14px;}.w1C3Le,.BmP5tf,.G5NbBd,.CS4w5b{padding-left:14px;padding-right:14px;}.G5NbBd{padding-bottom:12px}.CS4w5b{padding-top:12px}.nMymef{display:flex}.G5eFlf{flex:1;display:block}.nMymef span{text-align:center}.EYqSq{margin:6px 4px 9px 0;border-radius:100%;display:inline-block;height:10px;vertical-align:middle;width:10px}.dfB0uf{color:#3c4043;font-weight:bold}.IffyKc{word-wrap:break-word}
   </style>
   <div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECGMQAg" href="/url?q=https://www.sec.gov/divisions/enforce/claims/docs/mackay-objection-to-distribution-plan-110920.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECGMQAg&amp;usg=AOvVaw1ko7PHnzXdOYOb5FnrxRrZ">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] MACKAY'S OBJECTIONS TO THE DISTRIBUTION PLAN | SEC.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › docs › mackay-objection-to-distribution-plan-110920
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 9, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Since Stiefel Labs was not publicly traded, this liquidation could only occur by selling the shares back to Stiefel Labs at the value assigned ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIYxAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIYxAG">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECGAQAg" href="/url?q=https://www.debevoise.com/-/media/files/insights/publications/2016/08/insider_trading_update_vol3issue1.pdf%3Frev%3D28491cd1194b4b938619ed3d0b53de3d%26hash%3DA2A7C28C557EB79C11F9738D780D6B4F&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECGAQAg&amp;usg=AOvVaw2UC1bnF1fiJOqPyXZkdcrD">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Insider Trading &amp; Disclosure Update - Debevoise &amp; Plimpton LLP
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.debevoise.com › media › files › insights › publications › 2016/08
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 9, 2016
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Fried sued Stiefel. Labs and other parties asserting various claims, including claims under the federal securities laws. The district court ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIYBAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIYBAG">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECGIQAg" href="/url?q=https://ir.bioventus.com/static-files/171189da-7a30-4e9b-9a62-d8f95188b5cd&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECGIQAg&amp;usg=AOvVaw0CLzN6y8LqQougZCmWoCEA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] united states securities and exchange commission - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.bioventus.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... acquired by Stiefel Laboratories, Inc. in 2008. Ms. Church began her career as an attorney at Hopkins &amp; Carley, a San Jose-based law firm. In 2020, Ms ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECF4QAg" href="/url?q=https://www.sos.arkansas.gov/uploads/rulesRegs/Arkansas%2520Register/2003/jul_2003/003.11.03-007.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECF4QAg&amp;usg=AOvVaw2FAjQPItjTVTTjBIlSRCw_">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] arkansas bureau of standards
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sos.arkansas.gov › rulesRegs › jul_2003 › 003.11.03-007.pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jul 1, 2003
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... laboratories, particularly related to the use of laboratory intercomparisons to demonstrate laboratory competence. To address these concerns ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECGEQAg" href="/url?q=https://xtalks.com/gsk-plans-to-shut-down-irish-skin-care-manufacturing-facility-in-second-plant-closure-announced-this-month-1549/&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECGEQAg&amp;usg=AOvVaw0119ncTMUCT78umNkkPGSq">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GSK Plans to Shut Down Irish Skin Care Manufacturing Facility in ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          xtalks.com › Vitals
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 23, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Unfortunately, it seems the plant is closing for good this time, with slow sales of Stiefel Laboratories' skin care products prompting GSK to ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIYRAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIYRAG">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECF8QAg" href="/url?q=https://ir.annexonbio.com/static-files/0f254990-b1a0-4e21-ab9f-e11550054991&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECF8QAg&amp;usg=AOvVaw21VmXEa5Hs7Iux7T1Dvk65">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 2024 Proxy Statement 2023 Annual Report - Annexon Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.annexonbio.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 25, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           when Connetics was acquired by Stiefel Laboratories, Inc. From 1992 ... compensation of Annexon, Inc.'s named executive officers as described in ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECF0QAg" href="/url?q=https://investor.assemblybio.com/static-files/15fb78cf-5c03-4ad1-b273-bd82e829070a&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECF0QAg&amp;usg=AOvVaw3YnVLbQkE1etDlFr-O3_u_">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form DEF 14A for Assembly Biosciences INC filed 04/17/2024
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.assemblybio.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 17, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Director at Stiefel Laboratories, Inc. Dr. Johnson-Pratt worked for ... Inc.'s 2024 Annual Meeting of Stockholders and Proxy Statement ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFwQAg" href="/url?q=https://ir.bankunited.com/static-files/513d0ca0-3058-4429-bb10-e2b89bb69936&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFwQAg&amp;usg=AOvVaw1Efb7q3OWA4iUCpS5RFd2i">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] united states securities and exchange commission - BankUnited, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.bankunited.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... relationship with the FDIC as a long-term partnership in which both parties ... Inc.'s main sources of funding include management fees and dividends ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFIQAg" href="/url?q=https://www.sec.gov/Archives/edgar/data/1557883/000104746914007229/a2221236zs-1.htm&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFIQAg&amp;usg=AOvVaw1iN_BLs3DR0NALyoCWlo5R">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           dermira, inc. - SEC.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › Archives › edgar › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           We or any partner with which we may collaborate may suffer significant setbacks in our clinical trials similar to the experience of a number of other companies ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIUhAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIUhAF">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFsQAg" href="/url?q=https://www.govinfo.gov/content/pkg/FR-2023-12-01/xml/FR-2023-12-01.xml&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFsQAg&amp;usg=AOvVaw0EQSPjKNyGKqoF8SBOb3pq">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [XML] FR-2023-12-01.xml - GovInfo
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.govinfo.gov › content › pkg › xml
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 1, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Laboratories:&lt;/SJ&gt; &lt;SJDENT&gt; &lt;SJDOC&gt;Labtest Certification Inc ... relationship between the national government and the States, or on the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFkQAg" href="/url?q=https://investor.aclaristx.com/static-files/5ae0aed2-cd12-4097-a607-5e3f45f57364&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFkQAg&amp;usg=AOvVaw26e6VChBlumhphy18h7tJ2">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Aclaris Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.aclaristx.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc.'s transfer agent, Broadridge Corporate Issuer Solutions, Inc., then you are a stockholder of record. As a stockholder of record, you may vote in person ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIWRAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIWRAF">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFoQAg" href="/url?q=https://ir.corbuspharma.com/all-sec-filings/content/0001144204-14-054047/0001144204-14-054047.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFoQAg&amp;usg=AOvVaw3RcZRRqb-t5sB4-4tMnivE">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form S-1 Corbus Pharmaceuticals Holdings, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.corbuspharma.com › all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 18, 1986
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... relationship with, or endorsement or sponsorship of us by, any other ... laboratories or packagers are responsible for the selection ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFcQAg" href="/url?q=https://ir.korewireless.com/all-sec-filings/content/0001628280-23-022947/0001628280-23-022947.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFcQAg&amp;usg=AOvVaw37-0vtpc1X8DCuwZO34-os">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] KORE Group Holdings, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.korewireless.com › all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 20, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Kennedy has also served as in-house counsel for Stiefel Laboratories, Inc., a specialty pharmaceutical company. ... In no event will the warrants ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFYQAg" href="/url?q=https://investor.streamlinehealth.net/node/11346/html&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFYQAg&amp;usg=AOvVaw1mIdjFGHgrp-w9tYCrGLcs">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Streamline Health Solutions - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.streamlinehealth.net › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc.'s internal control over financial reporting as of January 31, 2014, based ... Kennedy served as in-house counsel for Stiefel Laboratories, Inc., a ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFgQAg" href="/url?q=https://ir.agiletherapeutics.com/static-files/e60ce276-6099-401d-9553-70da11f811fc&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFgQAg&amp;usg=AOvVaw1hIrqma9Ge9Y9TAN8P5o5I">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] SCHEDULE 14A - Agile Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.agiletherapeutics.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 25, 2016
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Inc.'s independent registered public accounting firm for the ... Altomari completed the successful sale of Barrier to Stiefel Laboratories, which ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFUQAg" href="/url?q=https://s24.q4cdn.com/201644000/files/doc_financials/2022/ar/puma-biotechnology-2023-proxy-statement-bookmarked.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFUQAg&amp;usg=AOvVaw2-Y3wr3MDvOx9Pgt6qcrdy">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] You are invited to attend the annual meeting of stockholders of ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          s24.q4cdn.com › files › doc_financials › puma-biotechnology-2023-...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 28, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... acquired by Stiefel Laboratories, Inc. Previously, from 1997 to 2001 ... transition in the event of such a termination of employment in connection ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFQQAg" href="/url?q=https://pelotonsecuritiessettlement.com/Content/Documents/Declaration%2520of%2520James%2520Wilson.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFQQAg&amp;usg=AOvVaw36ZYUMCiAW7XpR8qJP8CS0">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Case 1:21-cv-02369-CBA-PK Document 97 Filed 04/24/24 Page 1 ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          pelotonsecuritiessettlement.com › Content › Documents
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 6, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Moreover, in In re Fox Entertainment Group, Inc. S'holders Litig. ... challenging the conduct of Abbott Laboratories and Laboratories Fournier in ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECD4QAg" href="/url?q=https://investors.zurabio.com/static-files/2c03a5a4-72e7-44f4-8047-cd015de23564&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECD4QAg&amp;usg=AOvVaw2kUky4cQK8nKYBhIJ6mnZ6">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] united states securities and exchange commission - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.zurabio.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc.'s anti-IL7R assets that were marked for disposal a number of years ago ... (Stiefel), Hoffman-la Roche and Millennium Pharmaceuticals before its ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFEQAg" href="/url?q=https://investors.gettyimages.com/node/13001/html&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFEQAg&amp;usg=AOvVaw3Ddo9ijfKRpgcfNSuD-6Mh">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           securities and exchange commission - SEC Filing - Getty Images
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.gettyimages.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Stiefel Laboratories and SunGard Data Systems, Inc. Mr. Chu received a B.S. ... , in the event that any Identified Person acquires knowledge of a ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFMQAg" href="/url?q=https://www.ontarioca.gov/sites/default/files/Ontario-Files/Planning/EIRs%252045%2520Day%2520Review/Merrill%2520Commerce%2520Center%2520SP/Liberty%2520%2528GH%2520Dairy%2529%2520Phase%2520I.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFMQAg&amp;usg=AOvVaw1_fhZ7gJlEqoji0CrNXGR-">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] PHASE I ENVIRONMENTAL SITE ASSESSMENT GH DAIRY FARM ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ontarioca.gov › sites › default › files › Ontario-Files › Planning
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 11, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Van Vliet Dairy/Jack &amp; Mack Stiefel Dairy/Jack D Stiefel Dairy, 8571 Merrill Avenue, ... Environmental Data Resources, Inc.'s (EDR) City ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFAQAg" href="/url?q=http://investor.jazzpharma.com/static-files/85ab09f6-5aee-4335-a735-a2bb2b785c0c&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECFAQAg&amp;usg=AOvVaw2DtO7j4ADMA1jlqfmf1RC5">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] jazz pharmaceuticals public limited company
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.jazzpharma.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Laboratories, a pharmaceutical company. From 2000 to 2001, he served as Vice ... Inc.'s Executive Chairman and as a member of its board of directors ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECE8QAg" href="/url?q=https://www.bauschhealth.com/siteassets/PDF/BiovailS_4.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECE8QAg&amp;usg=AOvVaw27JzDoIOeqduf8Ks1qqDrm">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Biovail Corporation - Bausch Health
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bauschhealth.com › siteassets › PDF › BiovailS_4
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 13, 2010
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... connection with entering into the merger agreement, Mr. Pearson has entered into an employment agreement with Biovail and Biovail. Laboratories ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEwQAg" href="/url?q=https://www.federalregister.gov/documents/2017/01/09/2016-30409/occupational-exposure-to-beryllium&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEwQAg&amp;usg=AOvVaw3Z-JW5bZ8air3-LqBJEETh">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Occupational Exposure to Beryllium - Federal Register
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.federalregister.gov › documents › 2017/01/09 › occupational-exposu...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 9, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The RFI also cited studies describing the relationship between beryllium sensitization and CBD (67 FR at 70708). ... Stiefel et al., 1980 (1288)).
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECE0QAg" href="/url?q=https://ir.growgeneration.com/sec-filings/all-sec-filings/content/0001213900-20-015641/0001213900-20-015641.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECE0QAg&amp;usg=AOvVaw36VAUMaFrpvRa0F_YjW6vC">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] GrowGeneration Corporation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.growgeneration.com › sec-filings › all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 23, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Inc.'s business located in Michigan. In connection with the purchase of the assets, we entered into an asset purchase agreement through our ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECE4QAg" href="/url?q=https://bels.alabama.gov/wp-content/uploads/2019/05/2009-Agendas-Minutes.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECE4QAg&amp;usg=AOvVaw07eokywfrHCTs4xoaT0-hD">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 1 BOARD MEETING Montgomery, Alabama February 3, 2009
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          bels.alabama.gov › uploads › 2019/05 › 2009-Agendas-Minutes
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Communications Inc.'s Certificate of Authorization application. MOTION ... working relationship he had with his supervisor at ELDECO. 09-216. IT WAS ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEsQAg" href="/url?q=https://peia.wv.gov/Forms-Downloads/Documents/summary_plan_descriptions/SPD_ABD_2023_web.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEsQAg&amp;usg=AOvVaw3BXcuhgzHF2uu4qvfoZ02Y">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Summary Plan Description Plans A, B &amp; D - PEIA - WV.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          peia.wv.gov › summary_plan_descriptions › SPD_ABD_2023_web
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jul 1, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           dependent child's marriage is a qualifying event for the ... Medicis; Veltin - Stiefel, Altreno, Avita, Clindamycin, Tazorac, Ziana). 53 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEoQAg" href="/url?q=https://appliedantitrust.com/14_merger_litigation/cases_state/albertsons_kroger2022dividend/04_washington_state/0_deal/washington_sup_hearing_stay_opp2022_11_09.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEoQAg&amp;usg=AOvVaw151AnlgjUOzSwcIOZSnfSm">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] The Honorable Ken Schubert Hearing Date - Applied Antitrust Law
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          appliedantitrust.com › washington_sup_hearing_stay_opp2022_11_09
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 9, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ALBERTSONS COMPANIES, INC.'S MEMORANDUM OF. LAW IN OPPOSITION TO ... Stiefel, WSBA #56611. Paul M. Crisalli, WSBA #40681. Susan E. Llorens ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEkQAg" href="/url?q=https://strataskinsciencesinc.gcs-web.com/static-files/d3fbd44c-8385-4ef2-acd0-18defcf7512d&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEkQAg&amp;usg=AOvVaw07WYQH6Q51gat02ZNqp5CN">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Untitled - Investor Relations | STRATA Skin Sciences
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          strataskinsciencesinc.gcs-web.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           laboratories; a contract research organization to assist in monitoring ... Charles Stiefel, Gerald Wagner, and Dan W. Lufkin, Index No. 50026/2010 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEgQAg" href="/url?q=https://www.sdsu.edu/magazine/_files/360-2014-spring.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEgQAg&amp;usg=AOvVaw3eF7udTL6f-8ijCx6gQAWg">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] WHERE IN THE WORLD - San Diego State University
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sdsu.edu › magazine › _files › 360-2014-spring
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Stiefel Auditorium and another. 475-seat space within Charles Hostler Hall ... official relationship, thanks to a $20 million gift from the renowned San.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEYQAg" href="/url?q=https://www.fda.gov/media/71474/download%3Fattachment&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEYQAg&amp;usg=AOvVaw1pR6XGHaUdM7nqU2cFpNrM">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Approved Drug Products With Therapeutic Equivalence Evaluations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.fda.gov › media › download › attachment
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jul 28, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Laboratories, Inc., and approved by FDA on December 9,. 1983 ... Inc.'s tablets (NDA 021116) (previously known as Levothroid) previously ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEcQAg" href="/url?q=https://www.libertymutualgroup.com/about-lm/investor-relations/documents/ar-2008.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEcQAg&amp;usg=AOvVaw16eQbHhBTSsEH6jci8RLnY">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Hello. My name is Andrea King and I'm a Liberty Mutual policy
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.libertymutualgroup.com › investor-relations › documents
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2008
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           internal control over Liberty Mutual Holding Company Inc.'s (the Company) ... Stiefel Laboratories, Inc. Coral Gables, Florida. Kenneth N. Trask.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEUQAg" href="/url?q=https://www.osler.com/en/people/lawrence-e-ritchie/&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEUQAg&amp;usg=AOvVaw0LwV_ZKfafgby8XQFBXsqm">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Lawrence E. Ritchie - Osler, Hoskin &amp; Harcourt LLP
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.osler.com › Home › People
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           KRIM Biopharma Inc., as well as its directors, with respect to the defence of a breach of contract and oppression claim brought by Stiefel Laboratories, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEQQAg" href="/url?q=https://www.bioworld.com/content/biotechbig-pharma-collaborations-5&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEQQAg&amp;usg=AOvVaw1jDramNg1tzYYu9vjwkhvP">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Biopharma collaborations in 2009 - | BioWorld
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bioworld.com › content › biotechbig-pharma-collaborations-5
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Stiefel Laboratories Inc. Feasibility study to identify genetic markers ... lab equipment, intellectual property and other related products, Everything ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEIQAg" href="/url?q=https://annualreport.stocklight.com/nasdaq/aytu/231322499.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEIQAg&amp;usg=AOvVaw2fDFluGGJmS0Ihk4MG2bxS">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Aytu BioPharma Annual Report 2023
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          annualreport.stocklight.com › nasdaq › aytu
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Oct 12, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Actavis Laboratories FL, Inc. (“Actavis”) (acquired by Teva ... the party's relationship with us. These agreements also generally ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEEQAg" href="/url?q=https://www.annualreports.com/HostedData/AnnualReportArchive/j/NASDAQ_JAZZ_2017.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEEQAg&amp;usg=AOvVaw0G8NPZS87nUfpFqDS5ZHcj">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Jazz Pharmaceuticals plc Proxy Statement 2017 Annual Report
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.annualreports.com › HostedData › NASDAQ_JAZZ_2017
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 15, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... relationship to us that is material to that director's ability to be ... Stiefel Laboratories, Inc. Previously, from 1997 to 2001, he ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECD0QAg" href="/url?q=https://www.sandiego.gov/sites/default/files/item_5_-_sr_memo_hrb_university_cpu_workshop_july_2023_combined_1.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECD0QAg&amp;usg=AOvVaw0L-YuJONXP8Y25skzO-HRw">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] ITEM 5: University Community Plan Update Historic Preservation ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sandiego.gov › sites › default › files › item_5_-_sr_memo_hrb_...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jul 12, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... relationship between the Kumeyaay ancestors and the populations ... Stiefel and S. Gunderman (2012), R. McLean (2010), E. Schultz and K ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCIQAg" href="/url?q=https://materials.proxyvote.com/Approved/09075A/20230412/NOMNP_536418.PDF&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCIQAg&amp;usg=AOvVaw31Wq9vc3px8z6wDnLFpMpr">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] NOTICE &amp; PROXY STATEMENT Annual Meeting of Stockholders
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          materials.proxyvote.com › Approved › NOMNP_536418
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 17, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Bioventus Inc.'s independent registered public ... specialty pharmaceutical company that was acquired by Stiefel Laboratories, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEMQAg" href="/url?q=https://www.health.ny.gov/facilities/public_health_and_health_planning_council/meetings/2015-06-11/docs/full_agenda.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEMQAg&amp;usg=AOvVaw0ObgmVmUJ82KOrRrDJ5psx">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] June 11, 2015 - New York State Department of Health - NY.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.health.ny.gov › facilities › meetings › docs › full_agenda
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 11, 2015
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Sales Manager for Stiefel Laboratories (a GlaxoSmithKline company). ... any personal or financial interest or relationship they may have. A ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECD8QAg" href="/url?q=https://www.cadwalader.com/resources/clients-friends-memos/federal-securities-litigation-and-regulation-a-periodic-review-and-predictions-for-the-remainder-of-2019&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECD8QAg&amp;usg=AOvVaw31z-xrGxGylRkQmnxAghHf">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Federal Securities Litigation and Regulation: A Periodic Review and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cadwalader.com › resources › clients-friends-memos › federal-securit...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The Second Circuit amended its earlier decision in Martoma and left Newman's “meaningfully close” personal relationship ... Stiefel Labs., Inc., 756 F.3d 1310, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEAQAg" href="/url?q=https://sapagp.org/wp-content/uploads/2022/04/sapa-gp-AC-2022-v15.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECEAQAg&amp;usg=AOvVaw31D3wY_CVzHU6tjhFD5yVS">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] TURBO CHARGING INNOVATION IN THE NEW DECADE OF LIFE ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          sapagp.org › wp-content › uploads › 2022/04 › sapa-gp-AC-2022-v15
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 16, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Barrier was acquired by Stiefel. Laboratories in 2008, at a moment that the company reached annual revenue of $45 million. Between 1994 and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDwQAg" href="/url?q=https://ir.bankunited.com/static-files/0877f32b-9621-4b6c-8ef5-bf5a7caf3785&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDwQAg&amp;usg=AOvVaw1GMR0vavxCN9ZFfHJPDMjg">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Download DOC - BankUnited, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.bankunited.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc.'s prospectus for the common stock it will issue in connection with the merger. You may obtain additional information about BankUnited, Inc. and Herald ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDsQAg" href="/url?q=https://d18rn0p25nwr6d.cloudfront.net/CIK-0001800347/562bd2de-9fd6-4463-a8a8-7e50ad4a5f43.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDsQAg&amp;usg=AOvVaw36_gd8dM1avQAP1CY4E6gu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] united states securities and exchange commission - cloudfront.net
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          d18rn0p25nwr6d.cloudfront.net › CIK-0001800347
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 20, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Incorporated, SunGard Data Systems, Inc., Stiefel Laboratories, Freescale Semiconductor, Ltd. ... event will the Warrants be exercisable in ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDoQAg" href="/url?q=https://www.nceo.org/assets/pdf/samples/newsletter_09_2015.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDoQAg&amp;usg=AOvVaw10bZPs2r0oQOIOqSyYKvae">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] EMPLOYEE OWNERSHIP - NCEO
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.nceo.org › assets › pdf › samples › newsletter_09_2015
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 27, 2015
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Stiefel Labs., Inc. (N.D. Ga., No. 1:12-cv-03234-MHC, 6/18/15), a ... Inc.'s site makes it easy to promote via social media, or you can.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDkQAg" href="/url?q=https://www.orrick.com/-/media/Public/Files/News/2022/Ch-89-5th-Edition-excerpt.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDkQAg&amp;usg=AOvVaw21Y79QyFMfOBHCr1kIS_5P">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Chapter 89 Corporate Litigation Reporting Obligations - Orrick
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.orrick.com › media › Public › Files › News
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           2020). 14Finnerty v. Stiefel Laboratories, Inc., 756 F.3d 1310, 1316–17, 58 ... Healthcare, Inc.'s 10-K is illustrative. Its most detailed discus- sion ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDgQAg" href="/url?q=https://www.supremecourt.gov/DocketPDF/18/18-1289/95983/20190410134521426_USSC%2520FINAL%2520APPX%2520for%2520Writ%2520of%2520Certiorari.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDgQAg&amp;usg=AOvVaw0RPHnux9X4wOgTtTb-UbXl">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Final Petition for Writ of Certiorari - Supreme Court
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.supremecourt.gov › DocketPDF
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 13, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           dose!response relationship” shown in the Phase 2 study between the ... Pharmaceuticals US$, Inc.'s request for attorney fees under 35 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDcQAg" href="/url?q=https://data.sfgov.org/api/views/wr8i-kpa5/rows.csv%3FaccessType%3DDOWNLOAD%26bom%3Dtrue%26format%3Dtrue&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDcQAg&amp;usg=AOvVaw2zID9TQO4LeBZegzQ8z7B1">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           1 - San Francisco Open Data
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          data.sfgov.org › api › views › rows
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Laboratories Inc Revive Skincare Smtm Technology LLC Stardust Distributing ... Inc S &amp; Z Trading Co Donco &amp; Sons Inc. Black Butterfly Vermillion Graham ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDYQAg" href="/url?q=https://ir.bioventus.com/node/6546/html&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDYQAg&amp;usg=AOvVaw0A0irooZpewmo1DUTc9bni">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Bioventus Inc
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.bioventus.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc.'s stockholders and (ii) issue shares of Class B common stock to ... acquired by Stiefel Laboratories, Inc. in 2008. Ms. Church began her career ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDQQAg" href="/url?q=https://fr.gsk.com/media/2691/annual-report-2010.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDQQAg&amp;usg=AOvVaw0skjHL2ZXrGEQvl6UqA69k">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] GlaxoSmithKline Annual Report 2010
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          fr.gsk.com › media › annual-report-2010
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 1, 2011
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... relationship with a third party. Page 15. 13. GSK Annual Report 2010 ... Laboratories. • Amgen. • AstraZeneca. • Bristol-Myers Squibb. • Eli ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDMQAg" href="/url?q=https://ir.agiletherapeutics.com/node/11751/html&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDMQAg&amp;usg=AOvVaw0vNwCzEenxe82wLHXizahR">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Agile Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.agiletherapeutics.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Altomari completed the successful sale of Barrier to Stiefel Laboratories, which was subsequently acquired by GlaxoSmithKline plc. From 1982 to 2003, Mr ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDUQAg" href="/url?q=https://www3.epa.gov/pesticides/endanger/litstatus/effects/chloroth-final%2520.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDUQAg&amp;usg=AOvVaw0pAb_jKmDyMpvqmmduUpaE">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Chlorothalonil - EPA
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www3.epa.gov › pesticides › endanger › litstatus › effects
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 13, 2003
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           This document contains Syngenta Crop Protection,. Inc.'s assessment concerning risk to federally listed threatened and endangered ... Shults SK, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDEQAg" href="/url?q=https://alumni.oswego.edu/s/1552/images/editor_documents/oswego_fall_2017_low_res.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDEQAg&amp;usg=AOvVaw2jn9ryEo8J_C95IcwqN-qd">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Laker Career Connections - Oswego Alumni Association
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          alumni.oswego.edu › editor_documents › oswego_fall_2017_low_res
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           College Foundation Inc.'s board of direc- tors, Community Bank is pleased to ... The oldest grandchild, Liam Stiefel, had just completed his first year ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECC4QAg" href="/url?q=https://content.edgar-online.com/ExternalLink/EDGAR/0001564590-21-029113.html%3Fhash%3D949d4c90dd0ff8133e4023b235f3c9e7b16d8e58b9b8766448d9b141c4846aec%26dest%3Detwo-ex1015_589_htm&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECC4QAg&amp;usg=AOvVaw0T__DWYwCP_POMnHcY5HZu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           E2open Parent Holdings, Inc. (Form: 10-K, Received - EDGAR Online
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          content.edgar-online.com › ExternalLink › EDGAR
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 20, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Inc.'s (we, our, us, Company or E2open) current expectations and ... Stiefel Laboratories, Freescale Semiconductor, Ltd. Biomet, Inc ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDIQAg" href="/url?q=https://app.boardroomalpha.com/feed/sec/0001628280-24-010376&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDIQAg&amp;usg=AOvVaw2fn8iFHxbefyRrS0iWbC6S">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           10-K - Bioventus Inc. - BVS / 1665988 - 2024-03-12
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          app.boardroomalpha.com › feed › sec
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... relationship with, or endorsement or sponsorship of us by, these other ... Stiefel Laboratories, Inc. in 2008. Ms. Church began her career as an ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECC8QAg" href="/url?q=https://sdbj-com-images.s3.amazonaws.com/wp-content/uploads/2022/11/SD500-2022.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECC8QAg&amp;usg=AOvVaw1MJi7uu8pah8MIcV_8lGXA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] SAN DIEGO BUSINESS JOURNAL - AWS
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          sdbj-com-images.s3.amazonaws.com › wp-content › uploads › 2022/11
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 14, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           microfluidic detection technologies – the basis for 1859, Inc.'s ... Connetics until its acquisition by Stiefel Laboratories in 2006.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDAQAg" href="/url?q=https://www.doj.state.or.us/wp-content/uploads/2022/11/2022.11.09-Full-Filing-Document-Amicus.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECDAQAg&amp;usg=AOvVaw0k3HCV4qjFEPBZ3EO7UjoT">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] FILE AN AMICUS CURIAE BRIEF - Oregon Department of Justice
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.doj.state.or.us › 2022.11.09-Full-Filing-Document-Amicus.pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... stiefel@atg.wa.gov. Attorneys for Plaintiff State of. Washington. __X_____ via ... relationship.' ” Energy Reserves Group, Inc. v. Kansas Power · &amp; Light Co ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECC0QAg" href="/url?q=https://www.astro.org/ASTRO/media/ASTRO/Meetings%2520and%2520Education/PDFs/HeadNeck22/HN22_Abstracts.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECC0QAg&amp;usg=AOvVaw3GXg6GpFnS4gbJzAsgXy-k">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] ARTICLE IN PRESS - American Society for Radiation Oncology
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.astro.org › ASTRO › PDFs › HeadNeck22 › HN22_Abstracts
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           NIH, NCI, MD Anderson IRG, Charles and Daneen Stiefel Oropharyngeal. Fund ... relationship (49-71), improvement in intimacy (72-120). Respondents were ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCsQAg" href="/url?q=https://investors.gettyimages.com/static-files/72c0ce24-f71e-41c9-a472-553eb35cdbc3&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCsQAg&amp;usg=AOvVaw0Pt5tsR4ztI2Pz32fIOSQV">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] 0001410578-23-000254.rtf - Investor Relations - Getty Images
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.gettyimages.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Stiefel Laboratories and SunGard Data Systems, Inc. Mr. Chu received a B.S. ... Inc.'s Chief Marketing Officer from October 2018 until April 2021 and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCwQAg" href="/url?q=https://investor.aclaristx.com/static-files/011a108b-b7da-48e8-a03f-4c6f067d0825&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCwQAg&amp;usg=AOvVaw2LTTfvseLc4gu_IknZ3b-e">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Aclaris Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.aclaristx.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 26, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Stiefel Laboratories, each a dermatological pharmaceuticals company, from April 2011 to May 2013, serving as Director of Business ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQILBAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQILBAG">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCoQAg" href="/url?q=https://www.pharmalive.com/wp-content/uploads/2015/02/63481-MedAdNews-Apri.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCoQAg&amp;usg=AOvVaw2nDF4FtJFv7bNHs9EIfy5i">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] COMMUNICATIONS AGENCIES - PharmaLive
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.pharmalive.com › uploads › 2015/02 › 63481-MedAdNews-Apri
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Relationship. Management, Amgen Inc. JAY CARTER Senior VP, Director of ... Laboratories Inc., an affiliate of Chemo. Group, a Spanish-based global ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCQQAg" href="/url?q=https://nvlpubs.nist.gov/nistpubs/Legacy/SP/nistspecialpublication1009.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCQQAg&amp;usg=AOvVaw3vhKBn-w1o9lVNV4uhxsk2">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 2003 - 88th National Conference - NIST Technical Series Publications
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          nvlpubs.nist.gov › nistpubs › Legacy › nistspecialpublication1009
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The Board is also looking at our relationship with our technical advisors both from Measurement Canada and NIST. ... Background/Discussion: At the June 2002 NTEP ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCgQAg" href="/url?q=https://invivo.citeline.com/-/media/supporting-documents/in-vivo-issue-pdfs/iv1602_lrs.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCgQAg&amp;usg=AOvVaw3O-VWYmjsKMDuDX_AH3Lk2">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] orphan drugs - In Vivo
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          invivo.citeline.com › media › in-vivo-issue-pdfs › iv1602_lrs
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           physician relationship – making sure KoLs know you, that clinical ... Upsher-Smith Laboratories Inc.'s Proximagen Ltd. cns division and Saniona AB ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCYQAg" href="/url?q=https://casetext.com/case/southern-new-england-tele-v-global-naps&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCYQAg&amp;usg=AOvVaw0EsjlQAQDFUE_G8EgD0fhT">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Southern New England Telephone v. Global Naps, 624 F.3d 123
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          casetext.com › Browse cases › 2nd Cir. › Ct. App. › 2010 › August
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 25, 2010
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           had taken over Global NAPs Inc.'s network functions and customer contracts. ... Stiefel Labs., Inc. rejecting the "no harm, no foul" standard for ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCUQAg" href="/url?q=https://peia.wv.gov/Forms-Downloads/Documents/summary_plan_descriptions/PlanYear2023_PlanC.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCUQAg&amp;usg=AOvVaw0DhXso4HsXcoGdTXA04YHN">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Summary Plan Description PPB Plan C - PEIA - WV.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          peia.wv.gov › summary_plan_descriptions › PlanYear2023_PlanC
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jul 1, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           marriage is a qualifying event for the policyholder to remove the ... Medicis; Veltin - Stiefel, Altreno, Avita, Clindamycin, Tazorac, Ziana).
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCcQAg" href="/url?q=https://investors.amgen.com/node/21486/html&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCcQAg&amp;usg=AOvVaw1y5yq0N8zfK8sauSDmTWiP">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Amgen Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.amgen.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Stiefel Laboratories, Inc. 13. Table of Contents. In addition to competition ... relationship between the provider and the insurer. Dialysis ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCkQAg" href="/url?q=https://www.ftc.gov/legal-library/search%3Fsearch%3DLegal%2520considerations%2520and%2520compliance%2520in%2520real%2520estate%2520transactions%2520forums%2520G%25202604%26sort_by%3Dsearch_api_relevance%26page%3D1009&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCkQAg&amp;usg=AOvVaw37DwXa1_eZHwY-R4E7_bOi">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Legal Library: Search | Federal Trade Commission
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ftc.gov › legal-library › search
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           Acquired Party. Stiefel Laboratories, Inc. Acquired Entities. Stiefel Laboratories, Inc. Early Termination Notices · 20100168: Logitech International S.A. ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIKRAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIKRAF">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCMQAg" href="/url?q=https://planning.lacity.gov/eir/nops/ENV-2015-1192-EIR_appendices.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCMQAg&amp;usg=AOvVaw2d-OY6irmvPVLgiaC1Vp7G">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] INITIAL STUDY (Appendices) - Los Angeles City Planning
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          planning.lacity.gov › eir › nops › ENV-2015-1192-EIR_appendices
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Oct 12, 2015
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Inc.'s (EDR) City Directory Abstract is a screening tool designed to ... STIEFEL &amp; COMPANY. Haines &amp; Company. STONE STANLEY PRODUCTION.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECB8QAg" href="/url?q=https://pdf.dfcfw.com/pdf/H2_AN202404181630491705_1.html&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECB8QAg&amp;usg=AOvVaw2Dfb9YBbVQv1HhyWIDn-PE">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           DEF 14A
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          pdf.dfcfw.com › pdf › H2_AN202404181630491705_1
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 18, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Stiefel Laboratories, Inc. Dr. Johnson-Pratt worked for Merck &amp; Co ... relationship with us that would interfere with the exercise of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBsQAg" href="/url?q=https://deh.acgov.org/deh-assets/safe-drug/docs/Alameda%2520County%2520MED-Project%25202019%2520Unwanted%2520Medicine%2520Annual%2520Report%252003.01.2020.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBsQAg&amp;usg=AOvVaw2t7e6GWUQBcar1NLkFPX_m">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 2019 MED-Project Annual Report - deh.acgov.org - Alameda County
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          deh.acgov.org › deh-assets › safe-drug › docs
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 1, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Stiefel Laboratories, Inc. GlaxoSmithKline, LLC. ViiV Healthcare ... related to this event. The Vendor notified MED-Project that the ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIGxAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIGxAG">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCEQAg" href="/url?q=https://s24.q4cdn.com/201644000/files/doc_financials/2019/ar/Puma-2020-Proxy-Statement-Final-Bookmarked.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCEQAg&amp;usg=AOvVaw3Q-OPaD7cLDo3YfaEY7bvI">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] printmgr file
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          s24.q4cdn.com › Puma-2020-Proxy-Statement-Final-Bookmarked
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 27, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Stiefel Laboratories, Inc. Previously, from 1997 to 2001, Mr. Miller ... with a smooth transition in the event of such a termination of employment ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECB4QAg" href="/url?q=https://opengov.slocity.org/WebLink/DocView.aspx%3Fid%3D18384%26dbid%3D0%26repo%3DCityClerk&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECB4QAg&amp;usg=AOvVaw3f49fSHrNoPo8mKVsC3lGA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Untitled
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          opengov.slocity.org › WebLink › DocView
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Stiefel, Sam Agreement with S.L.O. '3-19-51 :rOlO Foothill Sant.Imp ... Inc s. No. 250.6 &amp; 216.1 1 772 parki District No. 1 Selling Bonds ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCAQAg" href="/url?q=https://www.aon.com/attachments/risk-services/fsg/AFSG-2011-Year-In-Review.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECCAQAg&amp;usg=AOvVaw1LnvgZN_h6euPX-4F-3PSF">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Legal News and Developments in Executive Liability - AON
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.aon.com › risk-services › fsg › AFSG-2011-Year-In-Review
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           trusting relationship with the CEO and provides the time needed to focus on strategic issues. ... ” In re Goldman Sachs Group, Inc. S'holder Litig., 2011 Del.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECB0QAg" href="/url?q=https://fintel.io/doc/sec-aytu-biopharma-inc-1385818-10k-2022-september-27-19262-6514&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECB0QAg&amp;usg=AOvVaw0PsCAF81rwD0HLflafYz-B">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Aytu BioPharma, Inc. - 10K - Annual Report - September 27, 2022
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          fintel.io › doc
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Sep 27, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Laboratories FL, Inc. (“Actavis”), which resolved all ongoing ... relationship with us. These agreements also generally provide that ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBwQAg" href="/url?q=https://patents.google.com/patent/EP1233756A4/en&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBwQAg&amp;usg=AOvVaw22k2sZTpDjZrYUQyYxLKcd">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           EP1233756A4 - Solid carriers for improved delivery of active ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          patents.google.com › patent
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Laboratories Clear micellized solutions of fat soluble essential nutrients ... Stiefel Laboratories TOPICAL COMPOSITIONS FOR SKIN TREATMENT.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad xpd EtOod pkphOe">
     <div class="kCrYT">
      <span class="cAuxJf">
       <div class="BNeawe">
        <span class="BNeawe">
         <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQsAR6BAgAEAE" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=nOeWZrzxGuXSp84P4uCh0Aw&amp;q=What+is+Evant,+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQsAR6BAgAEAE">
          <span>
           <span class="FCUp0c rQMQod">
            Images
           </span>
          </span>
         </a>
        </span>
       </div>
      </span>
      <div class="BNeawe tAd8D AP7Wnd">
       <span class="BNeawe">
        <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ7Al6BAgAEAI" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=nOeWZrzxGuXSp84P4uCh0Aw&amp;q=What+is+Evant,+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ7Al6BAgAEAI">
         <span class="tAd8D AP7Wnd">
          <span class="rQMQod Xb5VRe">
           View all
          </span>
         </span>
        </a>
       </span>
      </div>
     </div>
     <div>
      <div>
       <div>
        <div class="Xdlr0d">
         <div class="idg8be">
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAQ" href="https://www.google.com/imgres?imgurl=x-raw-image:///93e31424f7cb09ea360352d19a11f59976500c8eb697f9b68b0a56cf1af9f045&amp;imgrefurl=https://www.sec.gov/divisions/enforce/claims/docs/mackay-objection-to-distribution-plan-110920.pdf&amp;h=2071&amp;w=1600&amp;tbnid=6gnL9yQU45PneM&amp;q=What+is+Evant,+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;tbnh=150&amp;tbnw=116&amp;usg=AI4_-kRQOukpkHlwLdhfpLiXVWM2i-6YuQ&amp;vet=1&amp;docid=otYWaMscHvhgWM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAQ">
           <div>
            <img alt="Objection - FINAL" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSL55R6QpKACawBPW9wtHXV3lc0-622oPAYo62E4cd-V_nW82XL-Epb-C1rcA&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAY" href="https://www.google.com/imgres?imgurl=x-raw-image:///cd4c9dcf463b509c1a0232d84e33b02fbf0b01eb2272081f8a09b712890cb2ee&amp;imgrefurl=https://www.pdl.com/static-files/4f9b3d3b-c51a-41ba-8a0f-8f144aaf1ffb&amp;h=2264&amp;w=1600&amp;tbnid=nFA7Rs-dTM0lRM&amp;q=What+is+Evant,+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;tbnh=150&amp;tbnw=106&amp;usg=AI4_-kToByLQvdBykQjVsmmUSfONAzl_gQ&amp;vet=1&amp;docid=hK78DTPPM0V5KM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAY">
           <div>
            <img alt="UNITED STATES SECURITIES AND EXCHANGE COMMISSION Form 8-K/A ..." class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRouWwHxfAK0EdhQPffhlPB2KIFXbShMRo2t6QDdij7vr-W667cg4iJaO3XyQ&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAg" href="https://www.google.com/imgres?imgurl=x-raw-image:///365661e2912de45eb1d108478830ce6e06aedae07a3f230bac088783cd4c096f&amp;imgrefurl=https://investor.assemblybio.com/static-files/15fb78cf-5c03-4ad1-b273-bd82e829070a&amp;h=2264&amp;w=1600&amp;tbnid=XuQtkeJhVjbGIM&amp;q=What+is+Evant,+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;tbnh=150&amp;tbnw=106&amp;usg=AI4_-kQt0ejOsu_M0izcgS5v786GweL7XA&amp;vet=1&amp;docid=1LMQWwzmvy12IM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAg">
           <div>
            <img alt="Form DEF 14A for Assembly Biosciences INC filed 04/17/2024" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR76Z2fiJeRzn724hSArBobQbpXcv1Qe33Y9XJUO1b529rIu2qhKOo3zO6-&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAo" href="https://www.google.com/imgres?imgurl=https://i0.wp.com/xtalks.com/wp-content/uploads/2018/08/Stiefel_a_GSK_company_headquarters.jpg?fit%3D1200%252C798%26ssl%3D1&amp;imgrefurl=https://xtalks.com/gsk-plans-to-shut-down-irish-skin-care-manufacturing-facility-in-second-plant-closure-announced-this-month-1549/&amp;h=798&amp;w=1200&amp;tbnid=cLq_c08VKc-oEM&amp;q=What+is+Evant,+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;tbnh=100&amp;tbnw=150&amp;usg=AI4_-kRM3UcMoykvfKrP1C0aRx9OPrCRTw&amp;vet=1&amp;docid=12teMRa1HESCqM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAo">
           <div>
            <img alt="GSK Plans to Shut Down Irish Skin Care Manufacturing Facility in ..." class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSdGqoBf6mT-7uBNbHQM1bM4X4TGXV78gFrOZLdoPawB7EJh6K-jcK4PRMifw&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAw" href="https://www.google.com/imgres?imgurl=x-raw-image:///0a3a15e541f797cbf22c6b0dfa6fd8899d1a9822f2458cfcd4b8783bea445de8&amp;imgrefurl=https://investor.aclaristx.com/static-files/0252600a-9038-42dc-a090-270df324927e&amp;h=2264&amp;w=1600&amp;tbnid=y5f3QeUVOgriyM&amp;q=What+is+Evant,+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;tbnh=150&amp;tbnw=106&amp;usg=AI4_-kQU6_fo32Che6hiwPMr4bERSY37aA&amp;vet=1&amp;docid=wwT6PDXPpKOpVM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEAw">
           <div>
            <img alt="Form DEF 14A for Aclaris Therapeutics INC filed 04/20/2023" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcT1yZ6tCr0svfTrk2sUep1-0_DKHnmsjMg8-RWQyHtjDlR3hndUf5qTLW4L9w&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEA4" href="https://www.google.com/imgres?imgurl=https://www.sec.gov/Archives/edgar/data/1846253/000184625323000055/def14aproxycard002.jpg&amp;imgrefurl=https://www.sec.gov/Archives/edgar/data/1846253/000184625323000055/oabi2022proxya.htm&amp;h=1365&amp;w=1055&amp;tbnid=GFOpPHUNmfJckM&amp;q=What+is+Evant,+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;tbnh=150&amp;tbnw=116&amp;usg=AI4_-kS9sT3pBo5OTf9QBQUdtVFg2_x7uw&amp;vet=1&amp;docid=KCHWsdIieJ9VLM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ9QF6BAgAEA4">
           <div>
            <img alt="OABI 2022 Proxy" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRtkjfUdbYzewrbOOFCAkjOylCfeYhPLlOC7XshNRXEArEgwkeStYTSpYgn&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <div class="mHhylf">
           <div class="WZ5GJf">
            <a class="qN9Ked" data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ7Al6BAgAEA8" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=nOeWZrzxGuXSp84P4uCh0Aw&amp;q=What+is+Evant,+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ7Al6BAgAEA8">
             <button class="DXk5Me Qi9Fd" tabindex="-1">
              <span class="hWHuJ">
               <span class="Dk7jOe z1asCe lYxQe">
                <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
                 <path d="M12 4l-1.41 1.41L16.17 11H4v2h12.17l-5.58 5.59L12 20l8-8z">
                 </path>
                </svg>
               </span>
              </span>
             </button>
             <div class="BNeawe ji5jpf s3v9rd AP7Wnd">
              View all
             </div>
            </a>
           </div>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBkQAg" href="/url?q=https://ir.journeymedicalcorp.com/financials/sec-filings/content/0001104659-21-135431/0001104659-21-135431.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBkQAg&amp;usg=AOvVaw1edgh1w7uk-D-vfIcE9M9I">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] tm2122275-11_s1a - Journey Medical Corporation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.journeymedicalcorp.com › financials › sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 8, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           regulatory filings which Rose U had obtained from Stiefel Laboratories (“Stiefel”). In connection with the license agreement, we assumed ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBoQAg" href="/url?q=https://investor.jazzpharma.com/node/8951/html&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBoQAg&amp;usg=AOvVaw25SXZondrbZ5zqcQUslWBy">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Jazz Pharmaceuticals plc
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.jazzpharma.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... acquired by Stiefel Laboratories, Inc. Previously, from 1997 to 2001, he ... Inc.'s stockholders in connection with Jazz Pharmaceuticals, Inc.'s ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBYQAg" href="/url?q=https://www.linkedin.com/posts/boxxinsurance_nyc-activity-7201266062145830914-OP3Z&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBYQAg&amp;usg=AOvVaw2O7C5UizBcrwud2KOEJuhR">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           BOXX Insurance Inc. on LinkedIn: #nyc
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.linkedin.com › posts
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 28, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           BOXX Insurance Inc.'s Post. View organization page for BOXX Insurance ... Stiefel who will be on-site at the event. #RIMS #BOXXInsurance ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBMQAg" href="/url?q=https://natlawreview.com/article/federal-securities-litigation-and-regulation-periodic-review-and-predictions&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBMQAg&amp;usg=AOvVaw11nYcpVvaqwwZfSkvNkPWm">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           What's Ahead Federal Securities Litigation and Regulation for 201
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          natlawreview.com › article › federal-securities-litigation-and-regulation-per...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 13, 2019
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The Second Circuit amended its earlier decision in Martoma and left Newman's “meaningfully close” personal relationship ... Stiefel Labs., Inc., ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBUQAg" href="/url?q=https://annualreport.stocklight.com/nasdaq/aytu/221271161.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBUQAg&amp;usg=AOvVaw0FY0XhbY4YKYFfpPJH6186">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Aytu BioPharma Annual Report 2022
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          annualreport.stocklight.com › nasdaq › aytu
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Sep 27, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... event that a potentially beneficial acquisition is discouraged, and ... Business and Puerto Rico for Stiefel, a GlaxoSmithKline plc company from ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBgQAg" href="/url?q=https://materials.proxyvote.com/Approved/03589W/20240408/COMBO_570810/INDEX.HTML%3Fpage%3D18&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBgQAg&amp;usg=AOvVaw2apS4S_-XOUTFWThL4rUrh">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           ANNEXON, INC. COMBO 2023 - 2024 - ProxyVote.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          materials.proxyvote.com › Approved › COMBO_570810 › INDEX
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... acquired by Stiefel Laboratories, Inc. From 1992 to 1994, Mr. Wiggans served ... Inc.'s named executive officers as described in Annexon, Inc.'s Proxy ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBcQAg" href="/url?q=https://www.annualreports.com/HostedData/AnnualReportArchive/p/NASDAQ_PRGO_2011.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBcQAg&amp;usg=AOvVaw1jwSJhkqMTlriRsBmYhKzP">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 2011 Annu A l R E po R t - AnnualReports.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.annualreports.com › HostedData › NASDAQ_PRGO_2011
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 16, 2011
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Stiefel Laboratories (Stiefel), a subsidiary of GlaxoSmithKline. In ... continued regulatory progress related to the Company's recent acquisition ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBIQAg" href="/url?q=http://webcast-law.uchicago.edu/briefs/2004-1609AppendixSix.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBIQAg&amp;usg=AOvVaw2aiGWo-3K07a-wHdtc_1At">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] JOINT APPENDIX - The University of Chicago
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          webcast-law.uchicago.edu › briefs
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 22, 2004
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Inc.'s Pretrial. Materials dated February. 20, 2002 ... relationship between the infringement and plaintiff's lost sales. Minco, lnc. v ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBQQAg" href="/url?q=https://www.jdsupra.com/legalnews/federal-securities-litigation-and-79388/&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBQQAg&amp;usg=AOvVaw15-KM3LqQE9r45y7Ozr-Ss">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Federal Securities Litigation and Regulation: A Periodic Review and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.jdsupra.com › legalnews › federal-securities-litigation-and-79388
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 13, 2019
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The Second Circuit amended its earlier decision in Martoma and left Newman's “meaningfully close” personal relationship ... Stiefel Labs., Inc., ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBEQAg" href="/url?q=http://www.pharmalive.com/wp-content/uploads/2015/02/89445-MedAdNews-Octo.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBEQAg&amp;usg=AOvVaw1r2mHoMEvprCDspsJJCf2m">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] MedAdNews - PharmaLive
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.pharmalive.com › uploads › 2015/02 › 89445-MedAdNews-Octo
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Stiefel Laboratories Inc. – acquired by GSK during July 2009 for £2.2 billion ($3.5 billion), agreed to a global deal in June 2012 to acquire. Toctino ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECA8QAg" href="/url?q=https://benefitslink.com/src/ctop/Wheaton_NDIll_09012017.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECA8QAg&amp;usg=AOvVaw0vqtymk_WsAJ4su3iFDbtJ">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 1:16-cv-04232 Document #: 86 Filed: 09/01/17 Page 1 of 3 PageID
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          benefitslink.com › src › ctop › Wheaton_NDIll_09012017
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Sep 1, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Clinic, Inc.'s Foreclosure Defense Project. Jamie Bowers. Jamie ... approved the repurchase of Stiefel Labs., Inc. stock from ESOP ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECA4QAg" href="/url?q=https://www.govinfo.gov/content/pkg/USCOURTS-cand-5_19-cv-00212/pdf/USCOURTS-cand-5_19-cv-00212-0.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECA4QAg&amp;usg=AOvVaw1fTl6Cip_OYgZrmQ7QkD9p">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Case 5:19-cv-00212-EJD Document 58 Filed 01/25/21 Page 1 of 31
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.govinfo.gov › pkg › pdf › USCOURTS-cand-5_19-cv-00212-0
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           No 45-2, Declaration of Holger Reisinger in Support of. GN Audio USA Inc.'s Motion for Summary Judgment (“Reisinger Decl. ... that relationship, Caule was granted ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBAQAg" href="/url?q=https://150154.fs1.hubspotusercontent-na1.net/hub/150154/file-70145103.pdf/convoy-therapeutics-executive-informational-overview-06-17-2013.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECBAQAg&amp;usg=AOvVaw3JlLKCaEF6ZOS2AOHMJbiC">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Convoy Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          150154.fs1.hubspotusercontent-na1.net › hub › file-70145103.pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 17, 2013
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Retinoids: (e.g., Stiefel Laboratories, Inc.'s Soriatane®) Alleviates psoriasis symptoms but does not prevent recurrences after therapy is ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAwQAg" href="/url?q=http://pdf.secdatabase.com/2918/0001564590-19-004452.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAwQAg&amp;usg=AOvVaw2jDe1t77sZa-k_M2Pd9P1J">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Dermira, Inc. Form 10-K Annual Report Filed 2019-02-26
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          pdf.secdatabase.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 26, 2019
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Stiefel Laboratories, Inc., a GSK company (“Stiefel”), to obtain rights to intellectual property related to our hyperhidrosis program. In ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAsQAg" href="/url?q=https://www.libertymutualgroup.com/about-lm/investor-relations/documents/ar-2006.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAsQAg&amp;usg=AOvVaw2S_OzQi3ZBdORelh8hdqmg">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Liberty Mutual Group | 2006 ANNUAL REPORT
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.libertymutualgroup.com › investor-relations › documents
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Inc.'s financial reporting. Our internal control system was designed ... Stiefel Laboratories, Inc. Coral Gables, Fla. Kenneth N. Trask. President and.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECA0QAg" href="/url?q=https://blogs.orrick.com/securities-litigation/&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECA0QAg&amp;usg=AOvVaw24vFCJvN_YoM_owhRF8sbI">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Securities Litigation, Investigations and Enforcement - Orrick Blogs
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          blogs.orrick.com › securities-litigation
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Sep 11, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The SEC Staff were of the opinion that the Simplystocks.com stock giveaway would be an event of sale within the meaning of Section 2(a)(3) of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAoQAg" href="/url?q=https://www.supremecourt.gov/DocketPDF/17/17-874/23722/20171213150102062_ZPR%2520Investments%2520Petition%2520Appendix.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAoQAg&amp;usg=AOvVaw1VliB2M_SO0-bYnFsLS8wV">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Appendix - Supreme Court
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.supremecourt.gov › DocketPDF
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 4, 2011
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Stiefel Labs., Inc., 756. F.3d 1310, 1317 (11th Cir. 2014) (“[A] duty ... relationship with ZPRIM. Respondents offer no reason why.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAkQAg" href="/url?q=https://us.astfinancial.com/proxyservices/Files/AR01756.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAkQAg&amp;usg=AOvVaw0dqQykbpSJtf07xM21sFRE">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] DUSA PHARMACEUTICALS, INC. - AST Access
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          us.astfinancial.com › proxyservices › Files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           deferred cost of revenues of $42,000 related to the Company's termination of its Latin America distribution agreement with Stiefel Laboratories, Inc., or ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAYQAg" href="/url?q=https://ir.annexonbio.com/static-files/7e61afff-c047-4d43-a3cf-fbba32f1c6a4&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAYQAg&amp;usg=AOvVaw2k-64A7Lj8xgt8fhBOrQCn">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form DEF 14A for Annexon INC filed 04/25/2023
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.annexonbio.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 25, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           December 2006 when Connetics was acquired by Stiefel Laboratories, Inc. ... compensation of Annexon, Inc.'s named executive officers as described ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAUQAg" href="/url?q=https://ddd.uab.cat/pub/infanu/43623/iaGSKa2010ieng.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAUQAg&amp;usg=AOvVaw2qMx5HJAIdTelF_T4Jy52T">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] GlaxoSmithKline Annual Report 2010 - DDD UAB
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ddd.uab.cat › pub › infanu
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 1, 2011
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... relationship with a third party. Page 15. 13. GSK Annual Report 2010 ... Laboratories. • Amgen. • AstraZeneca. • Bristol-Myers Squibb. • Eli ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAIQAg" href="/url?q=https://issuu.com/pstreeto/docs/medpub&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAIQAg&amp;usg=AOvVaw0CtcsmO4nOxmd75FO-UehS">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Medical Publication by Paul Streeto - Issuu
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          issuu.com › pstreeto › docs › medpub
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Generics company Impax Laboratories Inc.'s branded drug unit Impax ... Stiefel Laboratories Inc.........41. GE Healthcare...............37, 75.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAgQAg" href="/url?q=https://www.streetinsider.com/SEC%2BFilings/Form%2BPREC14A%2BAnika%2BTherapeutics%252C%2BInc.%2BFiled%2Bby%253A%2BAnika%2BTherapeutics%252C%2BInc./21419998.html&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAgQAg&amp;usg=AOvVaw244kslcTaRCkWtWQvUwEhu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Form PREC14A Anika Therapeutics, Inc. Filed by - StreetInsider
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.streetinsider.com › SEC+Filings
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 27, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... relationship; and (3) explore a “sale” or “going private ... Director and Chief Operating Officer of Stiefel Laboratories, Inc ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAEQAg" href="/url?q=https://www.researchgate.net/publication/280069113_P136_Rasch_Analysis_of_the_Psoriatic_Arthritis_Quality_of_Life_and_Dermatology_Life_Quality_Index_Measures_in_Psoriatic_Arthritis&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAEQAg&amp;usg=AOvVaw3qn_IZzJT01oq1AtohaLti">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           P136 Rasch Analysis of the Psoriatic Arthritis Quality of Life and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.researchgate.net › Home › Arthritis, Psoriatic
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... relationship between smoking, alcohol consumption, and comorbidities with ... Stiefel, Takeda, UCB Pharma,. Vertex, Wyeth, Speakers bureau of: 3M ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAcQAg" href="/url?q=https://www.zoedraelos.com/static/res/DraelosCV.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAcQAg&amp;usg=AOvVaw1095uagf2ifZkj-FCidPvN">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] CURRICULUM VITAE - Zoe Diana Draelos, MD
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.zoedraelos.com › static › res › DraelosCV
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Stiefel Laboratories, 2004. - An Evaluation of the Tolerance and Efficacy of ... Pharmaceutical Inc.'s Pimecrolimus Cream, 1% and Reference Listed ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIBxAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIBxAF">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAQQAg" href="/url?q=https://www.gsk.com/media/8071/20-f-2010.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAQQAg&amp;usg=AOvVaw1zApVEaFb0rH65UlfpaTwv">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] GSK Form 20-F 2010
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.gsk.com › media
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2010
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... relationship with a third party. GSK Annual Report 2010. Therapeutic ... Laboratories. • Amgen. • AstraZeneca. • Bristol-Myers Squibb. • Eli ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Evant,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIBBAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+%22Evant,%22+Inc.'s+relationship+to+Stiefel+Laboratories?&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5t4CegQIBBAG">
             <span class="XLloXe AP7Wnd">
              Evant,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAMQAg" href="/url?q=https://www.health.ny.gov/facilities/public_health_and_health_planning_council/meetings/2015-05-21/docs/exhibits.pdf&amp;sa=U&amp;ved=2ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQFnoECAMQAg&amp;usg=AOvVaw2q0eobMBNjs81k1kWTZFfg">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Exhibits - New York State Department of Health - NY.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.health.ny.gov › facilities › meetings › docs › exhibits
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 21, 2015
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Sales Manager for Stiefel Laboratories (a GlaxoSmithKline company). ... any personal or financial interest or relationship they may have. A ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <footer>
    <div>
     <div class="Gx5Zad xpd EtOod pkphOe BmP5tf">
      <div class="nMymef Va3FIb lVm3ye">
       <a aria-label="Next page" class="nBDE1b G5eFlf" href="/search?q=What+is+Evant,+Inc.%27s+relationship+to+Stiefel+Laboratories%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1402386822cb5d18&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=nOeWZrzxGuXSp84P4uCh0Aw&amp;start=100&amp;sa=N">
        Next &gt;
       </a>
      </div>
     </div>
    </div>
    <div id="EOlPnc">
     <div class="Srfpq">
      <div>
       <span class="EYqSq unknown_loc">
       </span>
       <span class="dfB0uf">
        New York NY, New York
       </span>
      </div>
      <span>
       From your IP address
      </span>
      <span>
       -
      </span>
      <a aria-label="Learn more about this location" class="IffyKc" href="/url?q=https://support.google.com/websearch%3Fp%3Dws_settings_location%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQty4IggQ&amp;usg=AOvVaw0jpivKIP2YlLOQhzpG7_v3" tabindex="0">
       Learn more
      </a>
     </div>
     <div>
      <a href="/url?q=https://accounts.google.com/ServiceLogin%3Fcontinue%3Dhttps://www.google.com/search%253Fhl%253Den%2526source%253Dhp%2526q%253DWhat%252Bis%252BEvant,%252BInc.%252527s%252Brelationship%252Bto%252BStiefel%252BLaboratories%25253F%2526btnG%253DGoogle%252BSearch%2526iflsig%253DAL9hbdgAAAAAZpb1q1qIWmvt_hmdJKxygxVBozIbC1E8%2526gbv%253D1%2526lr%253Dlang_en%2526gl%253Dus%2526num%253D100%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQxs8CCIME&amp;usg=AOvVaw2mOK5HdrT6_0KmuV2OP78v">
       Sign in
      </a>
     </div>
     <div>
      <a class="xeDNfc" href="https://www.google.com/preferences?hl=en&amp;fg=1&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQ5fUCCIQE">
       Settings
      </a>
      <a class="xeDNfc" href="https://policies.google.com/privacy?hl=en&amp;fg=1">
       Privacy
      </a>
      <a class="xeDNfc" href="https://policies.google.com/terms?hl=en&amp;fg=1">
       Terms
      </a>
      <a class="xeDNfc" href="/setprefs?hl=en&amp;prev=https://www.google.com/search?hl%3Den%26source%3Dhp%26q%3DWhat%2Bis%2BEvant,%2BInc.'s%2Brelationship%2Bto%2BStiefel%2BLaboratories?%26btnG%3DGoogle%2BSearch%26iflsig%3DAL9hbdgAAAAAZpb1q1qIWmvt_hmdJKxygxVBozIbC1E8%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26pccc%3D1&amp;sig=0_QtxmWExEmgzIZcxe1OuZJWT-Uas%3D&amp;cs=2&amp;sa=X&amp;ved=0ahUKEwi8r-v8wayHAxVl6ckDHWJwCMoQjcAJCIUE">
       Dark theme: Off
      </a>
     </div>
    </div>
   </footer>
  </div>
  <!-- cctlcm 5 cctlcm -->
  <textarea class="csi" name="csi" style="display:none"></textarea>
 </body>
</html>
